BIOXCEL THERAPEUTICS INC (BTAI) Stock Earnings & Estimates
NASDAQ:BTAI - US09075P2048 - Common Stock
3.96 USD
-1.28 (-24.43%)
3.88 USD
-0.08 (-2.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 380K | 1.38M 263.16% | 2.266M 64.20% | 811.512K -64.19% | 5.66M 597.46% | 56.192M 892.79% | 93.152M 65.77% | 164.52M 76.61% | 88.505M -46.20% | 147.69M 66.87% | 199.45M 35.05% | |
| EBITDA YoY % growth | -159.32M -49.40% | -167.301M -5.01% | -64.495M 61.45% | -45.638M 29.24% | -49.358M -8.15% | -29.779M 39.67% | -38.964M -30.84% | 10.71M 127.49% | 23.052M 115.24% | 74.766M 224.34% | 119.75M 60.17% | |
| EBIT YoY % growth | -159.65M -49.29% | -167.619M -4.99% | -64.804M 61.34% | -43.777M 32.45% | -43.14M 1.45% | -35.193M 18.42% | -39.525M -12.31% | 10.098M 125.55% | 22.644M 124.24% | 74.052M 227.03% | 118.83M 60.47% | |
| Operating Margin | -42,013.16% | -12,146.30% | -2,859.84% | -5,394.48% | -762.20% | -62.63% | -42.43% | 6.14% | 25.58% | 50.14% | 59.58% | |
| EPS YoY % growth | -94.59 -44.90% | -98.40 -4.03% | -25.97 73.61% | -5.41 79.16% | -3.43 36.56% | -0.82 76.14% | -1.01 -23.24% | 0.79 177.78% | 2.69 242.86% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.26 75.38% | -0.75 78.86% | -0.75 49.91% | -0.78 68.36% | -0.94 25.84% | -0.77 -2.25% |
| Revenue Q2Q % growth | 220.32K 2.95% | 297.84K -18.62% | 255K 51.79% | 255K 112.50% | 306K 38.89% | 459K 54.11% |
| EBITDA Q2Q % growth | -12.026M 10.97% | -10.934M -7.71% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.583M 15.70% | -12.771M -22.08% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -2.45 27.08% | -1.89 | -0.56 | -29.42% |
| Q1 2025 Q2Q % growth | -1.50 89.22% | -6.79 | 5.29 | 77.91% |
| Q4 2024 Q2Q % growth | -3.57 70.64% | -6.55 | 2.98 | 45.53% |
| Q3 2024 Q2Q % growth | -5.12 81.40% | -8.84 | 3.72 | 42.08% |
| Q2 2024 Q2Q % growth | -3.36 88.52% | -11.59 | 8.23 | 71.00% |
| Q1 2024 Q2Q % growth | -13.92 52.72% | -11.40 | -2.52 | -22.14% |
| Q4 2023 Q2Q % growth | -12.16 61.03% | -14.85 | 2.69 | 18.12% |
| Q3 2023 Q2Q % growth | -27.52 -15.28% | -21.28 | -6.24 | -29.32% |
| Q2 2023 Q2Q % growth | -29.28 -35.56% | -28.57 | -0.71 | -2.47% |
| Q1 2023 Q2Q % growth | -29.44 -64.29% | -26.41 | -3.03 | -11.48% |
| Q4 2022 Q2Q % growth | -31.20 -109.68% | -23.60 | -7.60 | -32.18% |
| Q3 2022 Q2Q % growth | -23.87 -55.42% | -22.03 | -1.84 | -8.35% |
| Q2 2022 Q2Q % growth | -21.60 -21.62% | -19.90 | -1.70 | -8.57% |
| Q1 2022 Q2Q % growth | -17.92 -3.70% | -18.71 | 0.79 | 4.24% |
| Q4 2021 Q2Q % growth | -14.88 -6.90% | -18.02 | 3.14 | 17.41% |
| Q3 2021 Q2Q % growth | -15.36 10.28% | -17.15 | 1.79 | 10.45% |
| Q2 2021 Q2Q % growth | -17.76 -4.72% | -17.71 | -0.05 | -0.30% |
| Q1 2021 Q2Q % growth | -17.28 -36.71% | -15.32 | -1.96 | -12.79% |
| Q4 2020 Q2Q % growth | -13.92 -93.33% | -15.62 | 1.70 | 10.87% |
| Q3 2020 Q2Q % growth | -17.12 -87.72% | -13.04 | -4.08 | -31.31% |
| Q2 2020 Q2Q % growth | -16.96 -96.30% | -12.22 | -4.74 | -38.77% |
| Q1 2020 Q2Q % growth | -12.64 -71.74% | -9.71 | -2.93 | -30.17% |
| Q4 2019 Q2Q % growth | -7.20 | -10.34 | 3.14 | 30.34% |
| Q3 2019 Q2Q % growth | -9.12 | -10.55 | 1.43 | 13.58% |
| Q2 2019 Q2Q % growth | -8.64 | -9.86 | 1.22 | 12.35% |
| Q1 2019 Q2Q % growth | -7.36 | -8.92 | 1.56 | 17.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 120K -89.13% | 255K | -135K | -52.94% |
| Q1 2025 Q2Q % growth | 168K -71.13% | 435.203K | -267.203K | -61.40% |
| Q4 2024 Q2Q % growth | 366K -2.66% | 720.803K | -354.803K | -49.22% |
| Q3 2024 Q2Q % growth | 214K -37.24% | 1.332M | -1.118M | -83.93% |
| Q2 2024 Q2Q % growth | 1.104M 141.58% | 774.384K | 329.616K | 42.56% |
| Q1 2024 Q2Q % growth | 582K 182.52% | 473.28K | 108.72K | 22.97% |
| Q4 2023 Q2Q % growth | 376K 56.67% | 725.353K | -349.353K | -48.16% |
| Q3 2023 Q2Q % growth | 341K 143.57% | 673.2K | -332.2K | -49.35% |
| Q2 2023 Q2Q % growth | 457K | 462.968K | -5.968K | -1.29% |
| Q1 2023 Q2Q % growth | 206K | 509.072K | -303.072K | -59.53% |
| Q4 2022 Q2Q % growth | 240K | 1.273M | -1.033M | -81.15% |
| Q3 2022 Q2Q % growth | 140K | 1.116M | -976K | -87.46% |
| Q1 2022 Q2Q % growth | 127.5K | -127.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 21.02% | 58.1% | 22.81% | 69.37% |
| Revenue | -36.84% | -65.89% | -50.18% | -71.85% |